An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.

Citation: Becker OM, Dhanoa DS, Marantz Y, Chen D, Shacham S, Cheruku S, Heifetz A, Mohanty P, Fichman M, Sharadendu A, Nudelman R, Kauffman M, Noiman S.: An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. J Med Chem, Volume 49 (11), 2006
Authors: Becker OM, Chen D, Cheruku S, Dhanoa DS, Fichman M, Heifetz A, Kauffman M, Marantz Y, Mohanty P, Noiman S., Nudelman R, Shacham S, Sharadendu A
Journal: J Med Chem
Year: 2006
DOI: 10.1021/jm0508641
PubMed: 16722631
Machine-readable: REST API RDF

Publication